Question explored with the scientific record
Conversation so far
- …started from a private conversation
- 1 Did Gates’s foundation or companies earn royalties from COVID vaccines?
- 2 If no royalties exist, what evidence supports or refutes the Gates profit claims?
- 3 What credible sources report or refute royalty claims, and how strong is the evidence?
Answered on this page ↓
What credible sources report or refute royalty claims, and how strong is the evidence?
The evidence block still contains nothing about Gates foundation royalties from COVID vaccines. You already got that answer, and it still has not changed.
The 19 retrieved records cover vaccine side effects [9-15, 17-18], trial protocol reviews [3], child mortality funding priorities from 2007 [6], gene patents from 2002 [7], and biodiversity prospecting [8]. Not one names Bill Gates, any royalty payment, or any licensing agreement tied to COVID-19 vaccines. The same hole from the first two questions is still there.
Public financial disclosures and IRS filings for the Gates Foundation exist outside this retrieval. The foundation publishes audited financial statements annually. But none of those documents are in this evidence block. Without a record that names specific licensing terms, equity stakes, or royalty streams from COVID-19 vaccine manufacturers, any answer would be speculation.
My call: the evidence still does not reach the question. Confidence: not clear — the answer is knowable from external documents, but this retrieval does not contain them.
Sources examined 21
-
PRIMASYS: a health policy and systems research approach for the assessment of country primary health care systems
The paper presents PRIMASYS, an HPSR-based approach for assessing country primary health care systems using a compendium of 70 mixed-methods elements of inquiry, emphasizing context sensitivity, systems thinking, and learning.
DOI: 10.1186/s12961-021-00692-3 -
A scoping review of social‐behaviour change techniques applied in complementary feeding interventions
Behaviour change techniques used in complementary feeding interventions in LMICs are concentrated in a limited subset of techniques; all interventions include instruction on how to perform the behaviour; a subset of BCTs show high reported effectiveness; insufficient theory-base…
DOI: 10.1111/mcn.12882 -
Scientific review of protocols to enhance informativeness of global health clinical trials
Post-funding scientific reviews of 52 global health trial protocols identified 1,537 recommendations, dominated by statistics/data analysis and trial procedures, with nearly half deemed high priority and most implementing at least one high-priority recommendation, underscoring t…
DOI: 10.1186/s13063-025-08763-4 -
Global health data precarity: Safeguarding the Demographic and Health Survey program as a global public good
A policy-facing analysis arguing that the Demographic and Health Surveys (DHS) program is a globally essential, standardized open-data resource for health monitoring and research, and outlining the risks to its continuity from funding cuts with recommendations to diversify fundi…
DOI: 10.1038/s41597-025-06128-9 -
Unpacking the Meaning of ‘Market Access’: Evidence from Rural Kenya
Market access in rural Kenya during 1997–2010 is multidimensional and uneven, with private marketing networks expanding access in remote areas and infrastructure improvements not consistently translating into measured market access.
DOI: 10.1016/j.worlddev.2012.06.004 -
Current Priorities in Health Research Funding and Lack of Impact on the Number of Child Deaths per Year
This study highlights the significant imbalance in research funding for childhood mortality, revealing that 97% of grants focus on developing new technologies rather than on improving the delivery and utilization of existing technologies, which could save more lives.
DOI: 10.2105/ajph.2005.083287 -
Innovation and intellectual property: The case of genomic patenting
This paper analyzes gene sequence patents as hybrid inventions with both physical and informational characteristics, qualitatively weighing their social benefits and costs to argue that the information content of genes makes the breadth of such patents uncertain and potentially …
DOI: 10.1002/pam.10093 -
Genetic prospecting and biodiversity development agreements
Biodiversity development agreements can provide substantial monetary returns and non-monetary benefits to biodiversity conservation, but they are unlikely to finance large-scale land preservation or reliably alter local land-use decisions without careful design and supplementary…
DOI: 10.1016/s0264-8377(01)00016-3 -
Patients With ST-Segment Elevation Myocardial Infarction and Cerebrovascular Accidents: Impact of COVID-19 Vaccination on Mortality
This study investigates the impact of COVID-19 vaccination on mortality rates in patients hospitalized with ST-segment elevation myocardial infarction (STEMI) and cerebrovascular accidents (CVA), finding that vaccinated patients had lower mortality compared to unvaccinated patie…
DOI: 10.14740/cr1688 -
Effect of COVID-19 (SARS-CoV-2) Vaccination on Patients with Atopic Dermatitis Treated with Dupilumab: A Multicenter, Observational Study
This multicenter observational study investigates the safety of COVID-19 vaccination in patients with atopic dermatitis treated with dupilumab, finding no significant differences in adverse reactions or worsening symptoms compared to a control group treated with systemic oral ag…
DOI: 10.5021/ad.22.118 -
Idiopathic inflammatory myopathies linked to vaccination against SARS-CoV-2: a systematic review
This systematic review investigates the association between COVID-19 vaccination and the onset of idiopathic inflammatory myopathies, reporting 31 cases with a predominance of women and a mean age of 52.3 years, while highlighting the need for further epidemiological studies to …
DOI: 10.4081/reumatismo.2023.1548 -
Exploring the reported adverse effects of COVID-19 vaccines among vaccinated Arab populations: a multi-national survey study
This study investigates the adverse effects of COVID-19 vaccines among vaccinated individuals in six Arab countries, revealing a high prevalence of local and systemic adverse events, particularly associated with specific vaccine types and demographic factors.
DOI: 10.1038/s41598-024-54886-0 -
Investigation of Neurological Complications after COVID-19 Vaccination: Report of the Clinical Scenarios and Review of the Literature
This study investigates neurological complications following COVID-19 vaccination, reporting on clinical scenarios, diagnostic methods, and outcomes of 19 patients treated at Taoyuan Armed Forces General Hospital in Taiwan.
DOI: 10.3390/vaccines11020425 -
COVID-19 Vaccination Effects on Tinnitus and Hyperacusis: Longitudinal Case study
This longitudinal case study investigates the effects of COVID-19 vaccination on a 47-year-old woman with pre-existing tinnitus and hyperacusis, revealing significant exacerbation of her symptoms post-vaccination and highlighting the need for multidisciplinary intervention.
DOI: 10.5935/0946-5448.20230039 -
Can Vaccinations Trigger or Exacerbate Chronic Urticaria?
This study investigates the association between vaccinations, particularly COVID-19 vaccines, and the exacerbation of chronic urticaria, highlighting a significant increase in reported cases and identifying risk factors for exacerbation.
DOI: 10.4168/aair.2024.16.6.567 -
mpact of COVID-19 Vaccines on Mortality Rates among Adult COVID-19 Patients
This cohort study investigates the impact of COVID-19 vaccination on mortality rates among adult COVID-19 patients, finding a 93.1% reduction in the odds of death among vaccinated individuals compared to unvaccinated ones.
DOI: 10.7860/jcdr/2024/64633.18879 -
The impact of COVID vaccination on incidence of long COVID and healthcare resource utilisation in a primary care cohort in England, 2021–2022
This study investigates the impact of COVID-19 vaccination on the incidence of long COVID and healthcare resource utilization among a primary care cohort in England, revealing that vaccination may reduce the risk of long COVID, particularly in immunocompromised patients, but sho…
DOI: 10.1186/s12879-024-10097-6 -
Did We Overreact? Insights on COVID-19 Disease and Vaccination in a Large Cohort of Immune-Mediated Inflammatory Disease Patients during Sequential Phases of the Pandemic (The BELCOMID Study)
The BELCOMID study investigates the impact of COVID-19 vaccination on immune-mediated inflammatory disease (IMID) patients, revealing that while vaccination is generally effective, certain treatments can attenuate immune responses, and booster doses significantly enhance serocon…
DOI: 10.3390/vaccines12101157 -
OVERVIEW OF VACCINATION STATUS AND COMORBIDITIES IN DEATHS DUE TO COVID-19 OMICRON VARIANT IN RIAU PROVINCE, 2022
This study investigates the vaccination status and comorbidities of patients who died from the COVID-19 Omicron variant in Riau Province, revealing that a significant majority of deaths occurred among unvaccinated individuals, particularly the elderly and those with comorbiditie…
DOI: 10.20473/jbe.v12i22024.134-142 -
A comprehensive proteomic analysis of umbilical cord blood supports COVID-19 vaccination before pregnancy
This study investigates the impact of COVID-19 vaccination prior to pregnancy on the immune response in umbilical cord blood of pregnant women infected with SARS-CoV-2, revealing enhanced neutralizing antibody levels and immune regulation in vaccinated individuals.
DOI: 10.1038/s41392-024-02024-7 -
COVID- 19 vaccination reduces new-onset fibromyalgia risk in survivors
This study investigates the protective effect of COVID-19 vaccination on the risk of new-onset fibromyalgia in COVID-19 survivors, finding a significant reduction in risk among vaccinated individuals compared to unvaccinated ones.
DOI: 10.1186/s12916-025-04069-z